NTRA FY 2025 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

FY 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2.3B+35.9% YoY

Gross Profit

$1.5B64.8% margin

Operating Income

-$310M-13.4% margin

Net Income

-$208M-9.0% margin

EPS (Diluted)

$-1.52

Cash Flow

Operating Cash Flow

$215M

Free Cash Flow

$109M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$686M

Stockholders' Equity

$1.7B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.3B	$1.7B	+35.9%
Gross Profit	$1.5B	$1.0B	+46.2%
Operating Income	-$310M	-$222M	-39.4%
Net Income	-$208M	-$190M	-9.3%